CONMED | CNMD - 销售收入



金融业
股票价格
USD
资产
USD 2.31B
现金及等价物
USD 40.82M
销售成本
USD 133.6M
流动资产
USD 670.59M
流动负债
USD 292.72M
债务
USD 834.94M
股息收益率
1.48
EBIT
USD 25.42M
EBITDA
USD 56.39M
员工
3.9K
EPS每股收益
USD 0.89
股本和储备
USD 1.02B
销售毛利
USD 183.45M
债务利息支出
USD 7.06M
贷款资金
USD 834.23M
市值
USD 1.09B
净收入
USD 13.83M
营业费用
USD 291.63M
营业利润
USD 25.42M
普通股股本
USD 30.97M
PE价格收益
9.39
税前利润
USD 29.25M
销售收入
USD 317M
销售和管理费用
USD 141.7M
股票
USD 366.11M
贸易债权人
USD 105.42M
应收帐款人
USD 247.83M


销售 更改 日
3M USD 6B 100M 2026-03
Abbott USD 11.16B 300M 2026-03
Accuray USD 116.17M 14.63M 2024-12
AtriCure USD 141.2M 700K 2026-03
Avanos Medical USD 182.2M 1.3M 2026-03
Baxter International USD 2.7B 270M 2026-03
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
CONMED USD 317M 56.2M 2026-03
Cooper Companies USD 1.08B 57.4M 2026-03
Dexcom USD 1.19B 70M 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Globus Medical USD 759.85M 66.55M 2026-03
Inogen USD 74.93M 504K 2024-09
Insulet USD 761.7M 22.1M 2026-03
Integra LifeSciences USD 391.9M 43M 2026-03
Intuitive Surgical USD 2.77B 100M 2026-03
J&J USD 24.1B 500M 2026-03
Medtronic USD 9.8B 800M 2026-03
Merit Medical Systems USD 381.9M 12M 2026-03
Olympus JPY 295.28B 34.23B 2026-03
Orthofix International USD 219.91M 14.28M 2025-12
ResMed USD 1.4B 0 2026-03
Smith & Nephew USD 3.18B 353M 2025-12
Steris USD 1.59B 90M 2026-03
Stryker USD 6B 1.2B 2026-03
Tandem Diabetes Care USD 247.22M 43.18M 2026-03
Teleflex USD 548.3M 20.68M 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03